Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
- C. Dinardo, B. Jonas, K. Pratz
- MedicineThe New England journal of medicine
- 12 August 2020
TLDR
Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin.
- D. Meruelo, G. Lavie, D. Lavie
- BiologyProceedings of the National Academy of Sciences…
- 1 July 1988
TLDR
A chemotaxonomic study of Withania somnifera (L.) dun.
- A. Abraham, I. Kirson, E. Glotter, D. Lavie
- Chemistry
- 1 June 1968
Constitutents of Withania somnifera Dun. Part XII. The withanolides of an indian chemotype
- I. Kirson, E. Glotter, D. Lavie, A. Abraham
- Chemistry
- 1971
Eight new steroidal lactones of the withanolide series have been isolated from the leaves of Withania somnifera(Solanaceae) growing in North-Western India. This population of W. somnifera differs…
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial.
- C. Harrison, A. Vannucchi, S. Verstovsek
- MedicineThe Lancet. Haematology
- 2018
Constituents of Withania somnifera Dun. III. The Side Chain of Withaferin A*,1
- D. Lavie, E. Glotter, Y. Shvo
- Chemistry
- 1 June 1965
The chemical and biological properties of hypericin—a compound with a broad spectrum of biological activities
- G. Lavie, Y. Mazur, D. Lavie, D. Meruelo
- BiologyMedicinal research reviews
- 1 March 1995
Constituents of Withania Somnifera Dun. Part X The Structure of Withanolide D
- D. Lavie, I. Kirson, E. Glotter
- Chemistry
- 1968
Withanolide D, the major component of the leaves of Withania somnifera chemotype II, is a steroidal lactone of the withanolide type, isomeric with withaferin A. It has been identified as 5,…
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients
- E. Dann, O. Bairey, O. Paltiel
- MedicineBritish journal of haematology
- 7 June 2017
This multicentre study evaluated 5‐year progression‐free (PFS) and overall survival (OS) in early and advanced Hodgkin lymphoma (HL), where therapy was individualized based on initial prognostic…
Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin.
- G. Lavie, F. Valentine, D. Meruelo
- BiologyProceedings of the National Academy of Sciences…
- 1 August 1989
TLDR
...
...